NeuPath Health (NPTH.V) Stock Price

NeuPath Health Price

CLOSED
0.58
​
Market closed

Over the last 6 years NeuPath Health grew revenue by 9.8% annually, reaching 87.19 M CAD. For NeuPath Health, the net margin of -0.8% is up versus -5.3% a few years ago. The consensus 12-month price target for NeuPath Health is 0.51 CAD, about 12.1% below where the stock trades today. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.

NeuPath Health stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

NeuPath Health business model & stock analysis

NeuPath Health Inc, based in Mississauga, Ontario, operates a network of medical clinics in Ontario and Alberta providing chronic pain management, musculoskeletal, and sports injury rehabilitation services. The company offers workplace health services, independent medical assessments, and contract research to pharmaceutical firms, employing 152 full-time staff. Listed on December 3, 2019, it serves clients across Canada with specialized healthcare providers including physiatrists, neurologists, and athletic therapists.

Frequently asked questions about NeuPath Health

Analysts currently set an average price target of 0.51 CAD for the NeuPath Health stock (median: 0.51 CAD), implying -12.1 % versus the latest price. The consensus is based on 5 analyst ratings.

5 analysts currently rate the NeuPath Health stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect NeuPath Health to generate revenue of 93.25 M CAD and earnings per share of 0.08 CAD.

Converted at the current exchange rate, the NeuPath Health share trades at 0.37 EUR (0.58 CAD).

The expected revenue of NeuPath Health is 93.25 M CAD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of NeuPath Health is 4.50 M CAD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of NeuPath Health is currently 7.23. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the NeuPath Health stock.

The price-to-sales ratio (P/S) of NeuPath Health is currently 0.35. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the NeuPath Health stock.

The Eulerpool Quality Score for NeuPath Health is 4/10.

The ISIN of NeuPath Health is CA64133P1009. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of NeuPath Health is NPTH.V. The ticker symbol is used to trade NeuPath Health shares on the stock exchange.

Fair ValueTerminal
0.49 CAD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue per Employee
573,638.16 CAD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website neupath.com
Country
Currency
CAD
Initial public offering
Dec 3, 2019
ISIN
CA64133P1009
Cusip
64133P100
Market capitalization
32.66 M CADMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
7.25
P/Ee 2027
5.80
P/S
P/Se
0.35
EV/EBIT
16.56
P/B Ratio
1.58
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-2.74 %
Last updated Oct 19, 2026, 9:35 AM

NeuPath Health Peer Group

NeuPath Health FIGI

NPTH:CN · BBG00Q7B29B6NPTH:CV · BBG00R0ZBNF3NPTH:CJ · BBG00R0ZBNK7NPTH:TV · BBG00R0ZBNN4NPTH:TN · BBG00R0ZBNR0NPTH:TG · BBG00R0ZBNS9NPTH:TK · BBG00R0ZBNT8NPTH:TW · BBG00R0ZBNV5NPTH:DV · BBG00R0ZBNY2NPTH:DS · BBG00R0ZBNZ1NPTH:DG · BBG00R0ZBP13NPTH:QF · BBG00R0ZBP22